TCS, HDFCBANK, SBI Liquid Fund (G)
Nectar Lifesciences Ltd.
Nectar Lifesciences
NSE
₹ 0.00
0.00 (0.00)%
Healthcare
Small-cap
With a market cap of ₹18.90L Cr.
Moderate Volatility
Stock is 1.13x as volatile as index
| EX-Date | Purpose |
|---|---|
| 23 07 2021 | Audited Results & A.G.M. Inter alia, to consider amongst other items: 1. To Convene the Annual General Meeting of Members of the Company for the Financial Year 2020-21 and matters related thereto. 3. To fix Book Closure dates for the purpose of Annual General Meeting. |
| 14 08 2021 | Quarterly Results |
| 13 11 2021 | Quarterly Results |
| 14 02 2022 | Quarterly Results |
| 30 05 2022 | Audited Results |
| 13 08 2022 | Quarterly Results |
| 14 11 2022 | Quarterly Results |
| 14 02 2023 | Quarterly Results |
| 26 05 2023 | Audited Results & A.G.M. |
| 14 08 2023 | Quarterly Results |
| 10 11 2023 | Quarterly Results |
| 14 02 2024 | Quarterly Results |
| 14 11 2024 | Quarterly Results |
| 31 01 2025 | Quarterly Results |
News
No News data available
